News | August 08, 2025
Sigachi begins construction work for MCC capacity expansion at Dahej
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Subscribe To Our Newsletter & Stay Updated
